zilurgisertib as monotherapy or in combination with ruxolitinib in patients with mf-related anemia
Published 1 year ago • 66 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
1:54
limber-104 update: zilurgisertib as monotherapy or with ruxolitinib in patients with mf and anemia
-
3:30
limber-104: zilurgisertib /- ruxolitinib in patients with mf-associated anemia
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
2:21
an update from limber-104: zilurgisertib /- ruxolitinib in the management of mf-associated anemia
-
2:10
phase i study of ruxolitinib in combination with abemaciclib in patients with myelofibrosis
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
7:37
management of low-risk primary myelofibrosis
-
4:36
living in the moment with myelofibrosis—david’s mf journey
-
5:50
phase i/ii study evaluates zilurgisertib plus or minus ruxolitinib in myelofibrosis
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:16
the rationale for combining magrolimab with ruxolitinib in myelofibrosis
-
1:38
pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
2:04
phase i/ii study of a novel bet inhibitor, bms-986158, alone & with ruxolitinib or fedratinib in mf
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
4:33
the assessment and management of pain in patients with thalassemia
-
2:15
a phase i study investigating ruxolitinib and abemaciclib for primary or secondary myelofibrosis
-
2:54
ruxolitinib in the real world: myelofibrosis
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis